Efficacy of L-menthol(MINCLEA®) as an antispasmodic during endoscopic retrograde cholangiopancreatography(ERCP)
Phase 3
Recruiting
- Conditions
- biliary and pancreatic disease
- Registration Number
- JPRN-UMIN000008008
- Lead Sponsor
- Kyoto Second Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. the emergency patients 2. the patients with bad general conditions 3. the patients judged inappropriate by their doctors 4. contraindication of glucagon or L-menthol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the proportion of subjects with antiperistaltic effect
- Secondary Outcome Measures
Name Time Method 1. the proportion of subjects who finished the procedure without additional antispasmodic agents 2. complications 3. the interval from administration of antispasmodic agents to success of cannulation (except the subjects of post-sphincterotomy)